Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robin L. Smith currently holds 236,066 shares of Sorrento Therapeutics, Inc. (SRNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robin L. Smith has been a net buyer of SRNE stock. They have purchased $54.7M and sold $0 worth of shares.
Robin L. Smith's most recent insider trade was on Jun 14, 2023, when they sold 199,921 shares at $0.00 per share.
Robin L. Smith serves as Executive at Sorrento Therapeutics, Inc. (SRNE). They have executed 77 insider transactions totaling $54.7M over their tenure at the company.
Robin L. Smith holds the position of Executive at Sorrento Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Robin L. Smith has shown a buying trading pattern, with $54.7M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robin L. Smith was on Sep 3, 2021, when they sold $489.0K worth of SRNE shares. This transaction involved 100,000 shares at $4.89 per share.
Robin L. Smith currently owns 236,066 shares of Sorrento Therapeutics, Inc. (SRNE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robin L. Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robin L. Smith has 77 Form 4 filings on record as an insider at Sorrento Therapeutics, Inc..
Set alerts for Robin L. Smith and 40,000+ other insiders.